Welch, H.G., Fisher, E.S., Gottlieb, D.J. and Barry, M.J. (2007) Detection of Prostate Cancer via Biopsy in the Medicare-SEER Population during the PSA Era. Journal of the National Cancer Institute, 99, 1395-1400.
http://dx.doi.org/10.1093/jnci/djm119

has been cited by the following article:

• TITLE: Prevalence of Isolated “Pre-Malignant” Lesions on Prostate Biopsy in a Racially Diverse Community Screened Cohort

  AUTHORS: Michael A. Liss, Donna Ankerst, David Zapata, Javier Hernandez, Robin J. Leach, Ian M. Thompson

  KEYWORDS: Active Surveillance, Ethnicity, Prostate Biopsy, Prostate Cancer, Race

  JOURNAL NAME: Open Journal of Urology, Vol.5 No.12, December 17, 2015

  ABSTRACT: Objective: We investigated rates of prostate cancer (PCa), high-grade prostatic intraepithelial neoplaisa (HGPIN) and atypical small acinar proliferation (ASAP) in a multiethnic cohort. Methods: We evaluated prostate biopsy outcomes in men enrolled in the San Antonio Center of Biomarkers of Risk for prostate cancer (SABOR) prospective, observational study. PCa-free men underwent annual PSA testing over nearly 14 years with biopsies based on community standards. We investigated biopsy outcomes with a special interest in rates of cancer, HGPIN, and ASAP. Results: We identified 975 prostate biopsies in 801 subjects from 3/1/2001 to 1/9/2014. PCa, HGPIN, or ASAP was encountered in 28.8% (281/975), 10.1% (98/975), and 5.2% (51/975) of prostate biopsy specimens, respectively. The most significant risk factor for a PCa diagnosis was African American race (OR 5.0, 95% CI: 2.2 - 11.4, p